Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Lämnar över rodret på Vivolux

- Samarbetet med ledande cancerinstitut i USA och det nätverk jag byggt upp ger fina ingångar för Abigo, säger Hans Rosén, som lämnar rollen som vd på läkemedel...

Stöd till kvinnliga forskare

17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

Raysearch tappar chef

Finanschefen lämnar medtechbolaget i april.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Diamyd köper diabetesprojekt

Från GAD till GABA. Plockar upp nytt läkemedelsprojekt från USA.

Sales Representative, Applied Biosystems

Han leder nya Göteborgscentret

Professor Göran Landberg har utsetts till föreståndare för det nya Wallenbergcentret för molekylär och translationell medicin.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

EU stoppar utdelning av Humiradata

EMA, som arbetar för ökad öppenhet, hindras av EU-domstolen att lämna ut rådata gällande kliniska studier.

Lägger ner studie

Bioinvent avslutar en studie med antikroppen BI-505 mot blodcancerformen asymtomatiskt multipelt myelom.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Kliniska studier på cancer mer positiva än verkligheten

Yngre, friskare och mer välutbildade patienter förbättrar resultaten när cancerbehandlingar testas i kliniska studier. Det menar två cancerläkare i en artikel s...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Athera inleder fas I-studie

De första patienterna har behandlats i Atheras kliniska fas I-studie på hjärt-kärlsjukdomar.